Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.

dc.contributor.author	Ozgur, Emre
dc.contributor.author	Altun, Musa
dc.contributor.author	Gezer, Uğur
dc.contributor.author	Sahin, Dilek
dc.contributor.author	Sanli, Yasemin
dc.contributor.author	Ahmedova, Aysel
dc.contributor.author	Ozkaya, Kübra
dc.contributor.author	Tambas, Makbule
dc.date.accessioned	2021-03-04T12:25:20Z
dc.date.available	2021-03-04T12:25:20Z
dc.identifier.citation	Ahmedova A., Ozkaya K., Tambas M., Gezer U., Ozgur E., Sahin D., Sanli Y., Altun M., "Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.", 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35
dc.identifier.other	vv_1032021
dc.identifier.other	av_7732170e-a502-4710-ab99-0fa69cbb121c
dc.identifier.uri	http://hdl.handle.net/20.500.12627/81830
dc.identifier.uri	https://doi.org/10.1200/jco.2017.35.15_suppl.e17544
dc.language.iso	eng
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.title	Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	35
dc.contributor.firstauthorID	2504978

Files in this item

Files	Size	Format	View
There are no files associated with this item.